157 related articles for article (PubMed ID: 34159407)
1. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
Garip Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3421-3426. PubMed ID: 34159407
[TBL] [Abstract][Full Text] [Related]
2. Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.
Garip-Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Hintschich CR
Br J Ophthalmol; 2021 Jul; 105(7):1019-1023. PubMed ID: 32699051
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
Garip Kübler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
Orbit; 2023 Oct; 42(5):475-480. PubMed ID: 36128945
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy.
Garip Kuebler A; Wiecha C; Reznicek L; Klingenstein A; Halfter K; Priglinger S; Hintschich C
Eye (Lond); 2020 Sep; 34(9):1702-1709. PubMed ID: 32366997
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic model based on color vision examination for dysthyroid optic neuropathy using Hardy-Rand-Rittler color plates.
Liang J; Tian P; Wang J; Fan S; Deng X; Zhang J; Zhang J; Wang M; Zeng P
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2669-2678. PubMed ID: 37103624
[TBL] [Abstract][Full Text] [Related]
6. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
Wang S; Wang J; Chen L; Tan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
[TBL] [Abstract][Full Text] [Related]
8. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
[TBL] [Abstract][Full Text] [Related]
9. Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes.
Poonam NS; Alam MS; Oberoi P; Mukherjee B
Indian J Ophthalmol; 2022 Dec; 70(12):4419-4426. PubMed ID: 36453357
[TBL] [Abstract][Full Text] [Related]
10. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
Sears CM; Wang Y; Bailey LA; Turbin R; Subramanian PS; Douglas R; Cockerham K; Kossler AL
Am J Ophthalmol Case Rep; 2021 Sep; 23():101111. PubMed ID: 34113737
[TBL] [Abstract][Full Text] [Related]
11. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
[TBL] [Abstract][Full Text] [Related]
12. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
[TBL] [Abstract][Full Text] [Related]
14. Using frequency-doubling perimetry to detect optic neuropathy in patients with Graves' orbitopathy.
Monteiro MLR; Portes ALF; Moura FC; Regensteiner DBW
Jpn J Ophthalmol; 2008; 52(6):475-482. PubMed ID: 19089569
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
Park KA; Kim YD; In Woo K; Kee C; Han JC
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
[TBL] [Abstract][Full Text] [Related]
16. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.
Rudolph G; Dimitriadis K; Büchner B; Heck S; Al-Tamami J; Seidensticker F; Rummey C; Leinonen M; Meier T; Klopstock T
J Neuroophthalmol; 2013 Mar; 33(1):30-6. PubMed ID: 23263355
[TBL] [Abstract][Full Text] [Related]
17. Incidence of dyschromatopsy in glaucoma.
Bayer L; Funk J; Töteberg-Harms M
Int Ophthalmol; 2020 Mar; 40(3):597-605. PubMed ID: 31705359
[TBL] [Abstract][Full Text] [Related]
18. Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy.
Luo B; Liu R; Wang S; Hu W; Li Y; Tong B; Zhang H; Qi X
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):2031-2040. PubMed ID: 36642765
[TBL] [Abstract][Full Text] [Related]
19. Color vision in the tritan axis is predominantly affected at high altitude.
Tekavcic-Pompe M; Tekavcic I
High Alt Med Biol; 2008; 9(1):38-42. PubMed ID: 18331219
[TBL] [Abstract][Full Text] [Related]
20. The correlation between visual acuity and color vision as an indicator of the cause of visual loss.
Almog Y; Nemet A
Am J Ophthalmol; 2010 Jun; 149(6):1000-4. PubMed ID: 20378093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
